GENERIC NAME AVAILABLE AS PENICILLINS Amoxicillin Generic, Amoxil, others Amoxicillin/potassium clavulanate *Generic, Augmentin Ampicillin Generic Ampicillin/sulbactam sodium† Generic, Unasyn Dicloxacillin Generic, Dynapen Nafcillin Generic, Nallpen Oxacillin Generic, Bactocill Penicillin G Generic, Pfizerpen Penicillin G benzathine Permapen, Bicillin L-A Penicillin G procaine Generic Penicillin V Generic, V-Cillin, Pen-Vee K, others Piperacillin and tazobactam sodium‡ Zosyn CEPHALOSPORINS & OTHER BETA-LACTAM DRUGS Narrow-spectrum (first-generation) cephalosporins Cefadroxil Generic Cefazolin Generic, Ancef, Kefzol Cephalexin Generic, Keflex, others Intermediate-spectrum (second-generation) cephalosporins Cefaclor Generic Cefotetan Generic, Cefotan Cefoxitin Generic Cefprozil Generic Cefuroxime Generic, Ceftin, Zinacef GENERIC NAME AVAILABLE AS Broad-spectrum (third& fourth-generation) cephalosporins Cefdinir Generic Cefditoren pivoxil Spectracef Cefepime Generic, Maxipime Cefixime Suprax Cefotaxime Generic, Claforan Cefpodoxime proxetil Generic Ceftaroline fosamil Teflaro Ceftazidime Generic, Fortaz, Tazicef Ceftazidime/avibactam§ Avycaz Ceftibuten Generic, Cedax Ceftolozane/tazobactam|| Zerbaxa Ceftriaxone Generic, Rocephin Monobactam & Carbapenems Aztreonam Generic, Azactam, Cayston Doripenem Doribax Ertapenem Invanz Imipenem/cilastatin Generic, Primaxin IM, Primaxin IV Meropenem Generic, Merrem IV OTHER DRUGS DISCUSSED IN THIS CHAPTER Cycloserine Generic Dalbavancin Dalvance Daptomycin Cubicin Fosfomycin Monurol Oritavancin Orbactiv Telavancin Vibativ Vancomycin Generic, Vancocin PREP AR A TIONS A V AIL ABLE *Clavulanate content varies with the formulation; see package insert.
†Sulbactam content is half the ampicillin content.
‡Tazobactam content is 12.5% of the piperacillin content.
§Avibactam content is 25% of the ceftazidime content.
||Tazobactam content is half the ceftolozane content.
Biek D et al: Ceftaroline fosamil: A novel broad-spectrum cephalosporin with expanded Gram-positive activity. J Antimicrob Chemother 2010;65(Suppl 4):iv9.
Billeter M et al: Dalbavancin: A novel once-weekly lipoglycopeptide antibiotic. Clin Infect Dis 2008;46:577.
Boucher HW et al: Once-weekly dalbavancin versus daily conventional therapy for skin infection. N Engl J Med 2014;370:2169.
Carpenter CF, Chambers HF: Daptomycin: Another novel agent for treating infections due to drug-resistant gram-positive pathogens. Clin Infect Dis 2004;38:994.
Centers for Disease Control and Prevention (CDC): Antibiotic resistance threats in the United States, 2013. Available at: www.cdc.gov/drugresistance/ threat-report-2013/.